Belal Haschimi

Detection of the recently emerged synthetic cannabinoid 4F‐MDMB‐BINACA in “legal high” products and human urine specimens

Belal Haschimi, Lukas Mogler, Sebastian Halter et al. · Drug Testing and Analysis · 2019 · 54 citations

Pharmacy, Pharmacology, Toxicology +16

A transnational perspective on the evolution of the synthetic cannabinoid receptor agonists market: Comparing prison and general populations

Caitlyn Norman, Sebastian Halter, Belal Haschimi et al. · Drug Testing and Analysis · 2021 · 49 citations · Full text

Pharmacy, Pharmacology, Toxicology +15

Development and validation of a rapid LC‐MS/MS method for the detection of 182 novel psychoactive substances in whole blood

Arianna Giorgetti, Rossella Barone, Guido Pelletti et al. · Drug Testing and Analysis · 2021 · 40 citations · Full text

Pharmacy, Pharmaceutical Analysis, Toxicology +17

Four cases of death involving the novel synthetic cannabinoid 5F-Cumyl-PEGACLONE

Arianna Giorgetti, Lukas Mogler, Sebastian Halter et al. · Forensic Toxicology · 2019 · 35 citations · Full text

Pharmacy, Pharmacology, Toxicology +15

Impact of legislation on NPS markets in Germany – The rise and fall of 5F‐ADB

Sebastian Halter, Belal Haschimi, Lukas Mogler et al. · Drug Testing and Analysis · 2020 · 30 citations · Full text

Pharmacy, Pharmaceutical Policy, Pharmacology +12